Mesenchymal Stem Cell‐Derived Extracellular Vesicles as Mediators of Anti‐Inflammatory Effects: Endorsement of Macrophage Polarization. (31st January 2017)

• Record Type: Journal Article
• Authors: Lo Sicco, Claudia; Reverberi, Daniele; Balbi, Carolina; Ulivi, Valentina; Principi, Elisa; Pascucci, Luisa; Becherini, Pamela; Bosco, Maria Carla; Varesio, Luigi; Franzin, Chiara; Pozzobon, Michela; Cancedda, Ranieri; Tasso, Roberta
• Is Part Of: Stem cells translational medicine. Volume 6:Number 3(2017)
• Page Start: 1018
• Page End: 1028
• Publication Date: 2017-01-31
• Subjects: Extracellular vesicles -- Mesenchymal stem cells -- Inflammation -- Macrophages -- Cell hypoxia -- Regenerative medicine; Stem cells -- Periodicals; Regenerative medicine -- Periodicals; Periodicals; 616.0277405
• DOI: 10.1002/sctm.16-0363
• Languages: English
• ISSNs: 2157-6564

Abstract

Abstract: Mesenchymal Stem Cells (MSCs) are effective therapeutic agents enhancing the repair of injured tissues mostly through their paracrine activity. Increasing evidences show that besides the secretion of soluble molecules, the release of extracellular vesicles (EVs) represents an alternative mechanism adopted by MSCs. Since macrophages are essential contributors toward the resolution of inflammation, which has emerged as a finely orchestrated process, the aim of the present study was to carry out a detailed characterization of EVs released by human adipose derived‐MSCs to investigate their involvement as modulators of MSC anti‐inflammatory effects inducing macrophage polarization. The EV‐isolation method was based on repeated ultracentrifugations of the medium conditioned by MSC exposed to normoxic or hypoxic conditions (EV Normo and EV Hypo ). Both types of EVs were efficiently internalized by responding bone marrow‐derived macrophages, eliciting their switch from a M1 to a M2 phenotype. In vivo, following cardiotoxin‐induced skeletal muscle damage, EV Normo and EV Hypo interacted with macrophages recruited during the initial inflammatory response. In injured and EV‐treated muscles, a downregulation of IL6 and the early marker of innate and classical activation Nos2 were concurrent to a significant upregulation of Arg1 and Ym1, late markers of alternative activation, as well as an increased percentage of infiltrating CD206 pos cells. These effects, accompanied by an accelerated expression of the myogenic markers Pax7, MyoD, and eMyhc, were even greater following EV Hypo administration. Collectively, these data indicate that MSC‐EVs possess effective anti‐inflammatory properties, making them potential therapeutic agents more handy and safe than MSCs.Stem Cells Translational Medicine 2017 Stem Cells Translational Medicine 2017;6:1018–1028